Fasenra - Drug Insights, 2019-2021 - ResearchAndMarkets.com

DUBLIN--()--The "Fasenra - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

Fasenra - Drug Insight, 2019 report provides comprehensive information of the drug, Fasenra. It includes drugs overview, Fasenra mechanism of action, clinical trials, regulatory milestones, deals & Fasenra's partnerships. It further provides Fasenra's patents (US & EU) and its API manufacturers details in the United States, Europe, China and India.

It also features the historical and forecasted Fasenra sales till 2021. The report also throws light on Fasenra market competition and emerging therapies in the same space as Fasenra. Fasenra SWOT analysis is also featured.

Scope of the Report

  • A comprehensive Fasenra overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Fasenra Patent information in United States (US) and Europe (EU) has been highlighted
  • Fasenra API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Fasenra sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Fasenra operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Fasenra SWOT analysis

Reasons to Buy

  • Establish a comprehensive understanding of the drug, Fasenra
  • Access to Fasenra API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Fasenra patents for the major markets- US and EU
  • Understand current and future Fasenra's growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Fasenra
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Fasenra
  • Identify opportunities in the same area as with Fasenra SWOT analysis

Key Topics Covered

1. Report Introduction

2. Fasenra - Overview

  • Fasenra Product Description
  • Fasenra Route of Synthesis
  • Fasenra Mechanism of Action
  • Fasenra Pharmacology
  • Fasenra Pharmacodynamics
  • Fasenra Pharmacokinetics
  • Fasenra Adverse Reactions
  • Fasenra Clinical Trials
  • Fasenra Regulatory Milestones
  • Fasenra Development Activities

3. Global API Manufacturers

  • United States
  • Europe
  • China
  • India

4. Product Details

  • United States
  • Europe

5. Fasenra Global Sales Assessment

  • Fasenra Sales Global(Historical)
  • Fasenra Sales Global(Forecasted)

6. Fasenra Patent Details

7. Fasenra Market Competition

8. Fasenra Emerging Therapies

8.1. Drug name: Company name

  • Product Description
  • Research & Development
  • Product Development Activities

9. Fasenra SWOT Analysis

List of Tables

Table 1: Fasenra, Description

Table 2: API Manufacturers Region wise

Table 3: API Manufacturers for United States

Table 4: API Manufacturers for Europe

Table 5: API Manufacturers for China

Table 6: API Manufacturers for India

Table 7: Fasenra Product Details, United States

Table 8: Fasenra Product Details, Europe

Table 9: Fasenra, Historical Global Sales till 2017 (in million USD)

Table 10: Fasenra, Forecasted Global Sales from 2019-2021 (in million USD)

Table 11: Patent Details: Fasenra

Table 12: Fasenra Major Competitors

Table 13: Emerging Therapies

List of Figures

Figure 1: Fasenra

Figure 2: Fasenra, Historical Global Sales till 2017 (in million USD)

Figure 3: Fasenra, Forecasted Global Sales from 2019-2021 (in million USD)

Figure 4: Patent Details: Fasenra

Figure 5: API Manufacturers Region wise

For more information about this report visit https://www.researchandmarkets.com/r/amg2de

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900